ODDB.org: Open Drug Database

Swissmedic Registration	65173	Date of registration	10.11.2014
Company name	Janssen-Cilag AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Imbruvica 140 mg	Kapseln	Capsules (Ibrutinibum 140 mg)	L01EL01	CI

2025	©ywesee GmbH